Randomized Controlled Trial (RCT) in Children With Severe Pneumonia
NCT00455468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 368
Last updated 2011-07-12
Summary
Pneumonia is the leading cause of childhood morbidity and death in many developing countries including Bangladesh, causing about 2 million deaths worldwide each year. Pneumonia is an infection of the lungs, most commonly caused by viruses or bacteria like Streptococcus pneumoniae and Haemophilus influenzae. Depending on the clinical presentation, pneumonia can be classified as very severe, severe or non-severe, with specific treatment for each of them except for antibiotic therapy. Severe and very severe pneumonia require hospitalization for additional supportive treatment such as suction, oxygen therapy and administration of bronchodilator. In Bangladesh, the number of hospital beds is inadequate for admission of all pneumonia cases that require hospitalization; however, it is also important to provide institutional care to those children who cannot be hospitalized due to bed constraints. Provision of appropriate antibiotics and supportive cares during the period of stay at established day-care centres could be an effective alternative. The impetus for this study came from the findings of our recently completed study titled "Daycare-based management of severe pneumonia in under-5 children when hospitalization is not possible due to the lack of beds". This study successfully managed children (n=251), but it was not a randomized trial and thus direct comparison of the efficacy of management of severe pneumonia at the day-care centre, essential for building confidence for implementing this management policy, is not possible. We, the researchers at the International Centre for Diarrhoeal Disease Research, Bangladesh, could not plan a randomized, controlled trial (RCT) because of ethical reasons. Now that we have data suggesting effectiveness as well as safety of the day-care based treatment for management of children with severe pneumonia, a RCT should be possible. Two hundred fifty-one children with severe pneumonia were enrolled at the Radda Clinic from June 2003 to May 2005. The mean age was 7±7 (2-55) months, 86% infants, 63% boys and 91% breast-fed. History of cough was present in 99% cases, fever in 89% and rapid breathing in 67% cases. Forty-four percent of children were febrile (≥38°C), 93% children had vesicular breath sound and 99% bilateral rales. Fifty-seven percent of children were hypoxic with mean oxygen saturation of (93±4)%, which was corrected by oxygen therapy (98±3)%. Eighty percent of children had severe pneumonia and 20% had very severe pneumonia. The mean duration of clinic stay was (7±2) days. Two hundred thirty-four (93%) children completed the study successfully, 11 (4.4%) referred to hospitals (only one participant had to visit hospital at night due to deterioration of his condition, 9 were referred to hospital at the time of clinic closure i.e., at 5 pm and one participant was referred to hospital during the morning hours) and 6 (2.4%) left against medical advice (LAMA). There was no death during the period of clinic stay but only four (1.6%) deaths occurred during the 3 months follow-up. The study indicated that treatment of severe pneumonia in children at the day-care centre is effective and safe and thus it is comparable to the hospital care. If the day-care based management is found to have comparable efficacy to that of hospitalized management of severe pneumonia in children then they could be managed at outpatient, day-care set ups reducing hospitalization and thus freeing beds for management of other children who need hospitalized care. Additionally, availability of the treatment facility in community set-ups will be cost and time saving for the population. Children of either sex, aged 2-59 months, attending the Radda Clinic and Institute of Child Health and Shishu Hospital (ICHSH) with severe pneumonia will be randomized to receive either the day-care management at the clinic or hospitalized management at the ICHSH. Children randomized to receive day-care treatment will stay at the clinic from 8 am-5 pm and will receive antibiotics and other supportive cares. At 5 pm, they would be send to respective homes with advice to bring back their children to the clinic next morning, and advised to provide other supports at home. The same management would be continued till improvement and discharged and followed up every 2 weeks for 3 months. Children randomized to receive hospitalized management would be admitted at ICHSH and receive standard treatment like antibiotics and other supportive cares. The same treatment would be continued for 24 hours/day (rather than 9 hours/day at the day-care clinic) till improvement and discharged and followed-up at the ICHSH every 2 weeks for 3 months. About 3000 children with pneumonia visit Radda Clinic each year and about 200 of them will have severe pneumonia requiring hospitalization. Thus, we hope to enroll 368 (184 in each site) children with severe pneumonia during a 2-year study period.
Conditions
- Severe Pneumonia
Interventions
- PROCEDURE
-
Day-care treatment vs. hospital care
Sponsors & Collaborators
-
International Centre for Diarrhoeal Disease Research, Bangladesh
lead OTHER
Principal Investigators
-
Hasan Ashraf, MD · ICDDR,B: Centre for Health and Population Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Months
- Max Age
- 59 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Primary Completion
- 2007-12-31
- Completion
- 2009-04-30
Countries
- Bangladesh
Study Locations
More Related Trials
-
mHealth for Pneumonia Prevention
NCT04493047 ·Status: COMPLETED ·Phase: NA
-
Burden of Respiratory Illnesses in Pediatric Intensive Care Unit and Its Outcome
NCT05691127 ·Status: UNKNOWN
-
Research on the Treatment of Severe Community-acquired Pneumonia in Children
NCT05768204 ·Status: RECRUITING ·Phase: PHASE4
-
Azithromycin in the Prevention of Lung Injury in Premature Newborn
NCT03485703 ·Status: COMPLETED ·Phase: PHASE4
-
Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes
NCT04532346 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia
NCT03870243 ·Status: COMPLETED ·Phase: NA
-
Short Term Outcomes of Children With Acute Respiratory Distress Syndrome
NCT00142376 ·Status: COMPLETED
-
The Status Quo of Diagnosis and Treatment of Pediatric Outpatients With Respiratory Diseases
NCT04855604 ·Status: UNKNOWN
-
Prevention of Chronic Lung Disease (CLD) in Preterm Infants
NCT00883532 ·Status: UNKNOWN ·Phase: PHASE4
-
Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age
NCT05444699 ·Status: RECRUITING ·Phase: PHASE4
-
Pediatric Bronchiolitis Quality Improvement
NCT03528083 ·Status: COMPLETED ·Phase: NA
-
THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA
NCT06584474 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled NO in Prevention of Chronic Lung Disease
NCT00000548 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric Acute Respiratory Distress Syndrome Asia Study
NCT04068038 ·Status: COMPLETED
-
Feasibility Study for Neurodevelopment Follow-up Study in PICU
NCT03345628 ·Status: UNKNOWN
-
Atrial and Brain Natriuretic Peptides in Bronchiolitis
NCT00347880 ·Status: COMPLETED
-
Trial of Steroids in Pediatric Acute Lung Injury/ARDS
NCT01274260 ·Status: UNKNOWN ·Phase: PHASE2
-
Mortality in Pediatric Intensive Care Unit
NCT02961153 ·Status: COMPLETED
-
Non Invasive Positive Pressure Ventilation in Status Asthmaticus
NCT01403428 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant
NCT05311228 ·Status: COMPLETED ·Phase: PHASE4
-
Surfactant Nebulization for the Early Aeration of the Preterm Lung
NCT04315636 ·Status: COMPLETED ·Phase: PHASE3
-
Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)
NCT01356147 ·Status: COMPLETED ·Phase: PHASE4
-
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
NCT05285345 ·Status: RECRUITING
-
Hydroxychloroquin (HCQ) in chILD of Genetic Defect
NCT03822780 ·Status: COMPLETED ·Phase: NA
-
Observational Cohort Study of Distribution of Ventilation in Pediatrics Requiring Mechanical Ventilation by Electrical Impedance Tomography
NCT02247700 ·Status: COMPLETED